Analysts See Axonics Modulation Technologies Inc. (AXNX) Rising 42.73%

Publicly-traded company Axonics Modulation Technologies Inc. (NASDAQ:AXNX) had a closing price of $25.10 yesterday. Meanwhile, the average 12-month price target from Wall Street analysts is currently $43.83, this means that the stock is underpriced by 42.73%. In the past 52 weeks the company’s stock price has moved within the range of $11.95 to $43.37.

This particular stock’s 5-day moving average is 23.77, its 20-day moving average is 21.50 and its 100-day moving average is 32.03. Axonics Modulation Technologies Inc. (AXNX) currently has 28.09M shares outstanding, which means that its market capitalization is $705.06M.

The Details: Axonics Modulation Technologies Inc. (AXNX) Financial Health

We can also find the company’s Return on Assets, which is a percentage that shows us how well a company uses its current assets to make a profit. The larger the score, the better. At the moment, Axonics Modulation Technologies Inc. Return on Assets is -38.00%.

What Does Wall Street Say about Company?

When considering a stock buy, many investors seek to know what Wall Street analysts are saying about the company – by looking at the average analyst rating, for example. At the moment, the average analyst rating for AXNX is Buy. Out of 7 total analysts who were surveyed, 0 rated it a sell, 0 rated it a underweight, 0 rated it an overweight, 0 rated it hold, and 7 rated it a Buy.

Understanding Profitability at Axonics Modulation Technologies Inc. (AXNX)

A smart way of assessing a company’s profitability is by checking out its latest Earnings per Share (EPS). In the most recent financial results released by Axonics Modulation Technologies Inc., for the quarter ending on 09/2019, the company posted EPS of -0.72. The average estimate of Wall Street analysts had projected -0.70.

Wall Street analysts, on average, are forecasting the company’s EPS to be -0.75, compared to -2.67 reported in the same quarter last year. When it comes to net revenue, the average estimate from a total of 5 analysts is 1.45M – compared to 201k posted in the year-ago period.